
|Articles|September 1, 2002
Fluconazole Tx for cutaneous leishmaniasis
Riyadh, Saudi Arabia - For treatment of cutaneous leishmaniasis caused by Leishmania major, a six-week course of oral fluconazole is effective and avoids the potentially severe side effects of standard parenteral therapy, according to Abdulrahman A. Alrajhi, M.D., M.P.H.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














